Application of KRT15 in auxiliary diagnosis and targeted therapy of esophageal cancer
A technology for esophageal cancer and uses, applied in the field of esophageal cancer auxiliary diagnosis and targeted therapy by KRT15
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0063] Example 1 Expression of KRT15 in patients with esophageal cancer tissue
[0064] We used RNA in situ hybridization to analyze the expression of KRT15 in esophageal cancer tissues and its relationship with the prognosis of patients. 1013 postoperative tissue samples from esophageal cancer patients (without any preoperative treatment) collected in Linzhou Esophageal Cancer Hospital, Henan Province from 2011 to 2015 were selected for RNA in situ hybridization analysis. See the Materials and Methods section below for specific steps.
[0065] The results showed that the expression of KRT15 differed greatly among different esophageal cancer patients. It was highly expressed in 43.93% (445 / 1013) of esophageal cancer tissues (mean intensity × area score was above 3), 38.60% (391 / 1013) ) was not expressed in esophageal cancer tissues (the mean score of intensity × area was 0) ( figure 1 ). The correlation analysis of clinicopathological parameters showed that KRT15 expression...
Embodiment 2
[0069] Example 2 The effect of KRT15 on the proliferation of esophageal cancer cells
[0070] To explore the mechanism by which KRT15 promotes the development of esophageal cancer, we examined the effect of KRT15 on the malignant phenotype of esophageal cancer cells. The esophageal cancer cell lines KYSE150, KYSE450, and KYSE510 with high KRT15 expression were transiently transfected with two siRNAs specific for KRT15, respectively. The controls included parental group or transfection non-silence group. When the cells were completely adherent, the cell viability was detected by the CCK-8 method. The results showed that after knockdown of KRT15, the proliferation ability of esophageal cancer cells was significantly lower than that of the control group ( Figure 5 ).
Embodiment 3
[0071] Example 3 The effect of KRT15 on the distribution of esophageal cancer cell cycle
[0072] Flow cytometry was used to analyze the ratio of G0 / G1, G2 and S phase cells in the cell cycle, and the results showed that knockdown of KRT15 promotes G2 / M phase arrest in esophageal cancer cells ( 6A to 6B ).
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



